dc.description.abstract | TRIM proteins are E3 ubiquitin ligases, meaning that they modify other substrate proteins with
ubiquitin, either tagging them for destruction or influencing their function. We have focused on
three TRIM proteins, TRIM32, TRIM45, and TRIM27. Using in silico and in vitro methods we
have further elucidated the importance of TRIM proteins in tumorigenesis and autophagy.
In our study we found TRIM32 to be associated with head and neck cancer and patients with high
expression of TRIM32 having worse prognosis. TRIM32 might worsen the prognosis by
increasing glycolysis through MYC signaling, that could increase the expression of glycolytic
proteins, including HK2 and LDHA. This may further promote tumor growth, metastasis, and
proliferation. We also identified TRIM45 as an estrogen receptor (ER) associated gene, and that
higher TRIM45 expression improved the prognosis of ER-positive breast cancer patients. The
glycoprotein STC2 was found to be upregulated in response to elevated TRIM45 expression and
contributed to better prognosis. TRIM45 might be an estrogen responsive gene, but the exact
mechanism behind TRIM45 regulation and its cooperation with STC2 to improve prognosis needs
further research.
Lastly, in our project, TRIM27 was observed to induce clustering of mitochondria by interacting
with the selective autophagy receptor SQSTM1/p62. Additionally, the kinase TBK1 was involved
in the clustering process. TRIM27 is suspected to act as a scaffold for the activation of TBK1 and
SQSTM1/p62 to promote clustering of mitochondria and mitophagy. | en_US |
dc.description.popularabstract | Cancer is a disease, defined by uncontrollably cell growth and can potentially spread to other parts
of the body. The cancer cells, or the body’s reaction to cancer, can send out messages that can help
us understand the behavior of the cancer. Therefore, research today is actively trying to find these
messages and figure out how to use them to improve cancer treatment. These messages include
modifying TRIM proteins, that can tag other proteins for destruction or influence their function.
Using computational methods and lab experiments, we have identified that these modifying
proteins have an impact on the survival of cancer patients. These proteins can also take a part in
the clean-up of mitochondria, often called the powerhouse of the cell, which can have an effect on
cancer. Understanding the role of these modifying proteins in cancer can lead to the development
of new treatments, enhancing patient survival and overall well-being. | en_US |
dc.relation.haspart | Paper I: Berge, A.K.M., Sanchez, O.R.E., von Hofsten, S., Figenschaug, S., Schwienbacher, R., Five, M-B., Hegge, B., Sellæg, K., Magnussen, S.N., Sjøttem, E. & Knutsen., E. (2025). TRIM32 is associated with MYC signaling and poor prognosis in Head and Neck Squamous Cell Carcinoma. (Manuscript). <p>
<p>Paper II: Berge, A.K.M., Sanchez, O.R.E., Newmand, N., Figenschau, S., Albers, C., Hedberg, A., von Hofsten, S., Sjøttem, E., Kuijjer, M.L. & Knutsen, E., (2025). TRIM45 is a Positive Prognostic Marker in ER-Positive Breast Cancer. (Manuscript).<p>
<p>Paper III: Garcia-Garcia, J., Berge, A.K.M., Overa, K.S., Larsen, K.B., Bhajabal, Z., Brech, A., Abudu, Y.P., Lamark, T., Johansen, T. & Sjøttem, E. (2022). TRIM27 is an autophagy substrate facilitating mitochondria clustering and mitophagy via phosphorylated TBK1. <i>The FEBS Journal, 290</i>(4), 1096 – 1116. Also available in Munin: <a href=https://hdl.handle.net/10037/28048>https://hdl.handle.net/10037/28048</a>. | en_US |